ANIX
Price
$2.53
Change
-$0.21 (-7.66%)
Updated
Dec 18 closing price
13 days until earnings call
DNLI
Price
$21.43
Change
-$1.79 (-7.71%)
Updated
Dec 18 closing price
74 days until earnings call
Ad is loading...

ANIX vs DNLI

Header iconANIX vs DNLI Comparison
Open Charts ANIX vs DNLIBanner chart's image
Anixa Biosciences
Price$2.53
Change-$0.21 (-7.66%)
Volume$145.38K
CapitalizationN/A
Denali Therapeutics
Price$21.43
Change-$1.79 (-7.71%)
Volume$1.09M
CapitalizationN/A
ANIX vs DNLI Comparison Chart
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. DNLI commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Buy and DNLI is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ANIX: $2.53 vs. DNLI: $21.43)
Brand notoriety: ANIX and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 135% vs. DNLI: 134%
Market capitalization -- ANIX: $82.38M vs. DNLI: $3.08B
ANIX [@Biotechnology] is valued at $82.38M. DNLI’s [@Biotechnology] market capitalization is $3.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANIX and DNLI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 3 TA indicator(s) are bullish while DNLI’s TA Score has 4 bullish TA indicator(s).

  • ANIX’s TA Score: 3 bullish, 6 bearish.
  • DNLI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а -13.95% price change this week, while DNLI (@Biotechnology) price change was -10.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.12%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was -1.61%.

Reported Earning Dates

ANIX is expected to report earnings on Mar 14, 2025.

DNLI is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-7.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.08B) has a higher market cap than ANIX($82.4M). DNLI YTD gains are higher at: -0.140 vs. ANIX (-34.794).
ANIXDNLIANIX / DNLI
Capitalization82.4M3.08B3%
EBITDAN/AN/A-
Gain YTD-34.794-0.14024,890%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt149KN/A-
FUNDAMENTALS RATINGS
ANIX vs DNLI: Fundamental Ratings
ANIX
DNLI
OUTLOOK RATING
1..100
6356
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
10092
SMR RATING
1..100
9791
PRICE GROWTH RATING
1..100
6362
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANIX's Valuation (74) in the Computer Peripherals industry is in the same range as DNLI (94) in the Biotechnology industry. This means that ANIX’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's Profit vs Risk Rating (92) in the Biotechnology industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that DNLI’s stock grew similarly to ANIX’s over the last 12 months.

DNLI's SMR Rating (91) in the Biotechnology industry is in the same range as ANIX (97) in the Computer Peripherals industry. This means that DNLI’s stock grew similarly to ANIX’s over the last 12 months.

DNLI's Price Growth Rating (62) in the Biotechnology industry is in the same range as ANIX (63) in the Computer Peripherals industry. This means that DNLI’s stock grew similarly to ANIX’s over the last 12 months.

DNLI's P/E Growth Rating (99) in the Biotechnology industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that DNLI’s stock grew similarly to ANIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXDNLI
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with GERN. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-7.66%
GERN - ANIX
33%
Loosely correlated
-4.07%
SER - ANIX
27%
Poorly correlated
+27.97%
ALLO - ANIX
26%
Poorly correlated
-7.97%
SAGE - ANIX
26%
Poorly correlated
-4.55%
DNLI - ANIX
25%
Poorly correlated
-7.71%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-7.71%
BEAM - DNLI
65%
Loosely correlated
-7.45%
NTLA - DNLI
55%
Loosely correlated
-8.45%
RCKT - DNLI
54%
Loosely correlated
-1.51%
LGND - DNLI
53%
Loosely correlated
-5.00%
CRSP - DNLI
52%
Loosely correlated
-8.00%
More